Țară: Noua Zeelandă
Limbă: engleză
Sursă: Medsafe (Medicines Safety Authority)
Ceftriaxone sodium 2.386 g equivalent to Ceftriaxone 2g
Devatis Limited
Ceftriaxone sodium 2.386 g (equivalent to Ceftriaxone 2g)
2 g
Powder for infusion
Active: Ceftriaxone sodium 2.386 g equivalent to Ceftriaxone 2g
Prescription
Hanmi Fine Chemical Company Ltd
Infections caused by pathogens sensitive to ceftriaxone, e.g.: - sepsis - meningitis - abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts) - infections of the bones, joints, soft tissue, skin and of wounds; - infections in patients with impaired defence mechanisms - renal and urinary tract infections - respiratory tract infections, particularly pneumonia, and ear, nose and throat infections - genital infections, including gonorrhoea - Perioperative prophylaxis of infections.
Package - Contents - Shelf Life: Vial, glass, 50 cc Type II colourless glass vial with rubber stopper and aluminium flip-off cap - 1 dose units - 36 months from date of manufacture stored at or below 25°C protect from light 24 hours reconstituted stored at or below 25°C 3 days reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, 50 cc Type II colourless glass vial with rubber stopper and aluminium flip-off cap - 5 dose units - 36 months from date of manufacture stored at or below 25°C protect from light 24 hours reconstituted stored at or below 25°C 3 days reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, 50 cc Type II colourless glass vial with rubber stopper and aluminium flip-off cap - 10 dose units - 36 months from date of manufacture stored at or below 25°C protect from light 24 hours reconstituted stored at or below 25°C 3 days reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)
2015-04-15
Version NZ-V01 Page 1 CEFTRIAXONE 0.5 G & 1 G POWDER FOR INJECTION, CEFTRIAXONE 2 G POWDER FOR INFUSION DEVA _Ceftriaxone sodium _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about CEFTRIAXONE Powder for Injection /Infusion. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given CEFTRIAXONE Powder for Injection/Infusion against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT CEFTRIAXONE POWDER FOR INJECTION/INFUSION IS USED FOR CEFTRIAXONE Powder for Injection/Infusion contains ceftriaxone (as ceftriaxone sodium) as the active ingredient. CEFTRIAXONE Powder for Injection/Infusion is an antibiotic used to treat infections in different parts of the body caused by bacteria. It is also used to prevent infections before, during and after surgery. CEFTRIAXONE Powder for Injection/Infusion belongs to a group of antibiotics called cephalosporins. These antibiotics work by killing the bacteria that are causing your infection or by stopping bacteria from growing. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is available only with a doctor’s prescription. There is no evidence that it is addictive. Version NZ-V01 Page 2 BEFORE YOU ARE GIVEN IT _ _ _WHEN YOU MUST NOT BE GIVEN IT _ YOU MUST NOT BE GIVEN CEFTRIAXONE POWDER FOR INJECTION/INFUSION IF YOU HAVE HAD AN ALLERGIC REACTION TO: • any medicine containing ceftriaxone • any other cephalosporin antibiotic. YOU MUST NOT BE GIVEN CEFTRIAXONE POWDER FOR INJECTION/INFUSION IF YOU HAVE HAD A SERIOUS ALLERGIC REACTION TO PENICILLIN. Signs of an allergic reaction may include shortness Citiți documentul complet
CEFTRIAXONE 0.5 G & 1 G POWDER FOR INJECTION, CEFTRIAXONE 2 G POWDER FOR INFUSION MODULE 1.3.1 NEW ZEALAND DATA SHEET DEVATIS LIMITED Property-Strictly confidential Page 1/15 Version: NZ-V10 / October 2023 NEW ZEALAND DATA SHEET 1. NAME OF THE MEDICINAL PRODUCT CEFTRIAXONE 0.5 g & 1 g Powder For Injection & CEFTRIAXONE 2 g Powder For Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE Each 0.5 g vial contains Ceftriaxone sodium equivalent to 0.5 g of Ceftriaxone. Each 1 g vial contains Ceftriaxone sodium equivalent to 1 g of Ceftriaxone. Each 2 g vial contains Ceftriaxone sodium equivalent to 2 g of Ceftriaxone. EXCIPIENTS: For full list of excipients see 6.1. 3. PHARMACEUTICAL FORM Powder for Injection/Infusion Sterile, non-pyrogenic, almost white or yellowish, crystalline powder. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Infections caused by pathogens sensitive to ceftriaxone, e.g.: Sepsis Meningitis Abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts) Infections of the bones, joints, soft tissue, skin and of wounds Infections in patients with impaired defense mechanisms Renal and urinary tract infections Respiratory tract infections, particularly pneumonia, and ear, nose and throat infections Genital infections, including gonorrhea Perioperative prophylaxis of infections 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Considerations should be given to local guidelines on appropriate use of antibacterial agents. POSOLOGY _ADULTS AND CHILDREN OVER 12 YEARS _ The usual dosage is 1 to 2 g Ceftriaxone Injection once daily (every 24 hours). In severe cases or in infections caused by moderately sensitive organisms, the dosage may be raised to 4 g, once daily. Twice daily (12 hourly) administration may be considered where doses greater than 2g daily are administered. Specific dosage schedules _Gonorrhoea_ For penicillinase-producing and non-penicillinase-producing strains, give a single intramuscular dose of 250 mg. _ _ _Per Citiți documentul complet